ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TDOC vs PNTG // NET PROFIT MARGIN

Teladoc Health Inc. (NYSE) VS. The Pennant Group Inc. (NASDAQ) • 15-METRIC TALLY: TDOC 4 — PNTG 5
▲ NET PROFIT MARGIN LEADER: PNTG
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TDOC VS. PNTG) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TDOC PNTG SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -17.00% 11.00% -28.00 PNTG /roic <GO>
EV/EBITDA & P/E Valuation — 23.9x — TIE /valuation <GO>
Free Cash Flow Yield 18.00% 2.44% +15.56 TDOC /fcf-yield <GO>
Operating Margin -10.40% 5.50% -15.90 PNTG /operating-margins <GO>
Net Profit Margin ACTIVE -7.90% 3.10% -11.00 PNTG /net-margins <GO>
Revenue Growth (YoY) -1.50% 36.30% -37.80 PNTG /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.45 2.81 -2.36 PNTG /balance-sheet <GO>
Piotroski F-Score Quality 7/9 7/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 79.0 53.6 +25.39 TDOC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.08 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 32.0x 42.2x -10.20 TDOC /forward-pe <GO>
Enterprise Scale & Market Cap $1.59B $1.48B $102.3M TDOC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TDOC REV PNTG REV TDOC GROSS % PNTG GROSS % TDOC FCF PNTG FCF
FY 2025 $2.53B $947.7M — — $285.5M $36.3M
FY 2024 $2.57B $695.2M — — $282.9M $30.3M
FY 2023 $2.60B $544.9M — — $232.9M $33.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TDOC // BETA 1.08
PNTG // BETA —